Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung CancerCLINICAL CANCER RESEARCHIF10.22024-01-232PRE
Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patientsJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12024-01-015PRE
FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagyACTA PHARMACEUTICA SINICA BIF14.62022-09-015OAAI
Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics基于药代动力学和代谢组学的吉非替尼在EGFR敏感突变NSCLC患者中的合理应用ACTA PHARMACOLOGICA SINICAIF8.42021-11-043OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项